Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Signs and Symptoms » Neurologic Manifestations » Pain » Acute Pain
Description
Intensely discomforting, distressful, or agonizing sensation associated with trauma or disease, with well-defined location, character, and timing. MeSH
Hierarchy View
Approved Indicated Drugs (23)
Phase 4 Indicated Drugs (39)
Phase 2 Indicated Drugs (22)
Phase 1 Indicated Drugs (7)
Organization Involved with Phase 4 Indications (95)
Azienda Sanitaria dell'Alto Adige
British Columbia Emergency Health Services
Hackensack University Medical Center
Hamilton Health Sciences Corporation
Hersh, Elliot V., DMD, MS, PhD
Icahn School of Medicine at Mount Sinai
Mercy Health Partners, Cincinnati
Methodist Cancer Center, Houston, Texas
National Heart, Lung, and Blood Institute (NHLBI)
National Institutes of Health (NIH)
University of British Columbia
University of California, Davis
Organization Involved with Phase 3 Indications (54)
Autonomous University of Madrid
Centre Hospitalier de Cornouaille
Los Angeles Biomedical Research Institute
Medical Developments International Limited
Nova Scotia Health Research Foundation
Spanish Clinical Research Network
Organization Involved with Phase 1 Indications (14)
Organization Involved with Other Experimental Indications (25)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
